Tetherin antagonism by SARS-CoV-2 enhances virus release: multiple mechanisms including ORF3a-mediated defective retrograde traffic.

Stewart, Hazel; Palmulli, Roberta; Johansen, Kristoffer H; McGovern, Naomi; Shehata, Ola M; Carnell, George W; Jackson, Hannah K; Lee, Jin S; Brown, Jonathan C; Burgoyne, Thomas; Heeney, Jonathan L; Okkenhaug, Klaus; Firth, Andrew E; Peden, Andrew A; Edgar, James R.

Afiliación

Stewart H; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Palmulli R; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Johansen KH; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
McGovern N; Laboratory of Immune Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Shehata OM; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Carnell GW; Department of Biomedical Science, University of Sheffield, Firth Court, Sheffield. S10 2TN. UK.
Jackson HK; Department of Veterinary Medicine, University of Cambridge, Cambridge. CB3 0ES. UK.
Lee JS; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Brown JC; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Burgoyne T; Department of Infectious Disease, Imperial College London, London. W2 1PG. UK.
Heeney JL; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London. SW3 6NP. UK.
Okkenhaug K; UCL Institute of Ophthalmology, University College London, London. EC1V 9EL. UK.
Firth AE; Department of Veterinary Medicine, University of Cambridge, Cambridge. CB3 0ES. UK.
Peden AA; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.
Edgar JR; Department of Pathology, University of Cambridge, Cambridge. CB2 1QP. UK.